Mölnlycke Partners With Tissue Analytics


Mölnlycke, a world-leading medical solutions company, is pleased to announce a ground-breaking partnership with Tissue Analytics, a developer of a sophisticated digital wound imaging platforms. This exciting partnership brings together Mölnlycke's outstanding expertise in wound care and Tissues Analytics' advanced digital capabilities.

The two parties will jointly develop and commercialize innovative digital solutions for wound care practitioners including comprehensive clinical decision support tools that will significantly simplify and standardize wound assessment and treatment.

Today, practitioners are constrained by the quality of data available for wound assessment. Conditions, such as chronic wounds, burns and pressure ulcers are evaluated using only visual approximations.

Read Full Interview Here

Tissue Analytics (TA) develops software solutions that use artificial intelligence to automatically and objectively extract high quality data from input and images. Through partnerships with Epic, Cerner, Allscripts, and other EMRs (Electronic Medical Record), the extracted data can automatically be integrated into the institution's EMR system to allow efficiency and improved workflows.

Mölnlycke and Tissue Analytics will jointly develop TA's existing software, adding Mölnlycke's expertise in wound management and undertake extensive testing with clinical partners to ensure the best clinical and patient outcomes.

In addition, Mölnlycke has acquired a minority equity interest in Tissue Analytics that further solidifies the underlying strategic partnership.

"Mölnlycke is a world-leading producer of premium wound care products, and we bring to market new innovative solutions. However, we want to do more. By providing health care professionals with a combination of high quality products and advanced tools to allow consistent care delivery, we will not only help them in their daily job, but also improve patient outcomes. The partnership with Tissue Analytics represents a very exciting opportunity to make this happen", says Richard Twomey, CEO, Mölnlycke.

Kevin Keenahan, CEO of Tissue Analytics, comments:

"Tissue Analytics is incredibly excited to work with Mölnlycke on this important initiative. We share the same passion to help patients, and with our expertise in digital medicine and their extensive knowledge of wound healing, we can bring powerful, new data analytics capabilities to the market."

It's on us. Share your news here.

Submit your stories and articles to citybizlist today.